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and decreased choroidal thickness with regression
of punctate inner choroidopathy
Kiriko Hirooka1, Wataru Saito1,2*, Yuki Hashimoto1, Michiyuki Saito1 and Susumu Ishida1,2Abstract
Background: Changes in choroidal circulation hemodynamics during the course of punctate inner choroidopathy
(PIC) remain unknown. The aim of this study was to quantitatively evaluate changes in choroidal blood flow
velocity by using laser speckle flowgraphy (LSFG) in patients with PIC.
Case presentation: This PIC patient was initially treated with systemic corticosteroids for 4 months. LSFG
measurements were taken 10 consecutive times before treatment and at 1, 3, 12, 20 and 23 months after the initiation
of therapy. The mean blur rate (MBR), a quantitative index of relative blood flow velocity, was calculated using LSFG in
three regions: Circles 1, 2 and 3 were set at the fovea, a lesion site, and an area of normal-appearing retina, respectively.
The PIC lesions scarred after treatment along with improvements in visual function and outer retinal morphology. When
the changing rate of macular flow over the 12-month follow-up period was compared with the MBR before treatment
(100%), an increase of 16–37%, 24–49% and 15–18% was detected in Circles 1, 2 and 3, respectively. At the time of PIC
recurrence after 20 months, the MBR decreased temporarily but subsequently increased after retreatment with systemic
corticosteroids. This trend was accompanied by a decrease in choroidal thickness at the lesion site after retreatment.
Conclusions: Macular choroidal blood flow velocity increased and choroidal thickness decreased concurrently with
regression of PIC. The present findings suggest that inflammation-related impairments in choroidal circulation may relate
to the pathogenesis of PIC, extending over a wider area in the posterior pole than the PIC lesions per se.
Keywords: Choroidal blood flow velocity, Choroidal thickness, Enhanced depth imaging optical coherence tomography,
Laser speckle flowgraphy, Punctate inner choroidopathyBackground
Punctate inner choroidopathy (PIC) is an idiopathic
chorioretinitis with a predilection for young myopic
women. The condition is characterized by multiple punc-
tate yellow-white chorioretinal lesions that present mainly
in the posterior pole of the retina [1-4].
The pathogenesis of PIC is still largely unresolved. In-
docyanine green angiography (ICGA) images obtained
during the initial phase show hypofluorescence corre-
sponding to the PIC lesions, suggesting inflammation-
related choroidal circulation impairment [4,5]. The details* Correspondence: wsaito@med.hokudai.ac.jp
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unless otherwise stated.of changes in choroidal circulation hemodynamics during
the course of the disease remain unknown. Regarding the
depth of the associated pathology, PIC lesions appear
to affect the inner layer of the choroid, as indicated
by the name of the disease [1]. These observations are
based on previous studies using ICGA [5] and recent
spectral-domain optical coherence tomography (SD-OCT)
findings [6,7].
Laser speckle flowgraphy (LSFG) is a non-invasive tool
that can be used to measure the blood flow velocity of
ocular tissues including retinal and choroidal vessels
without the administration of contrast agents [8]. The
reproducibility of ocular blood velocity and flow mea-
surements obtained using LSFG is high, and the time re-
quired for obtaining measurements is shorter than that
required with the use of laser Doppler velocimetry [8,9].
The LSFG method is therefore suitable for monitoringl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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at various intervals during the course of disease [10]. In
the present study, we quantitatively measured choroidal
blood flow velocity at the macula using LSFG in a PIC
patient treated with systemic corticosteroids.
Case presentation
A 19-year-old woman noticed blurred vision with photo-
psia of the left eye. The patient had no notable medical
or family history. Her best-corrected visual acuity
(BCVA) was 1.0 OD and 0.9 OS with myopia of −9.0 di-
opters OU. Visual examination of the right eye showed
no abnormality. Slit-lamp biomicroscopy revealed mild
cells in the anterior vitreous OS. Funduscopic examin-
ation revealed multiple punctate yellow-white exudates
at the level of the retinal pigment epithelium (RPE) in the
posterior pole but not the midperiphery OS (Figure 1A).Figure 1 Photographs of the left eye at the initial visit (A-E) and 12 m
choroidopathy (PIC). A, Fundus photograph showing multiple punctate y
the posterior pole. B, Fluorescein angiography 600 second after dye in
C, The initial phase of indocyanine green angiography showing hypofluoresc
tomography (OCT) image through the fovea shows the loss of photoreceptor
fovea (D, arrows), and exudate appearing as a massive, moderately reflective l
F, The lesion was pigmented with some scarring. G, Horizontal cross-sectionaThese exudates appeared as initial hyperfluorescence with
late staining on fluorescein angiography (FA, Figure 1B)
and hypofluorescence during the initial phase of ICGA
(Figure 1C). SD-OCT images showed a loss of photorecep-
tor inner/outer segment junction (IS/OS) integrity corre-
sponding to the nasal fovea (Figure 1D), accompanied by a
moderately reflective, nodule-like lesion extending from
the outer nuclear layer to the choroid, which corresponded
to the exudates described above (Figure 1E). Humphrey
threshold 30–2 perimetry showed an area of decreased
sensitivity corresponding to the lesion area. Multifocal
electroretinography (mfERG) showed decreased ampli-
tudes at the posterior pole wider than the lesion area OS
and normal amplitudes OD. The patient received a diagno-
sis of PIC OS. A regimen of oral prednisolone (30 mg/day)
was initiated then gradually tapered for 4 months. Three
months after treatment, BCVA increased to 1.2 OS. Theonths after the initial visit (F, G) in a patient with punctate inner
ellow-white exudates at the level of the retinal pigment epithelium in
jection showing hyperfluorescence corresponding to the exudates.
ence corresponding to the lesions. D, E, Horizontal optical coherence
inner/outer segment junction (IS/OS) integrity in the nasal area of the
esion extending from the outer nuclear layer to the choroid (E, arrow).
l OCT showed the recovery of IS/OS integrity.
Hirooka et al. BMC Ophthalmology 2014, 14:73 Page 3 of 8
http://www.biomedcentral.com/1471-2415/14/73areas of exudate scarred as IS/OS line integrity recovered.
Twelve months after treatment, some of the scar lesions
developed hyperpigmentation (Figure 1F), whereas BCVA
and OCT findings remained stable.
Twenty months after the initial visit, the patient com-
plained again of central blurred vision in the left eye. Her
BCVA was 1.2 OS. A punctate subretinal yellowish-white
lesion nasal to the fovea OS (Figure 1A, F) appeared to
have increased in size (Figure 2A, arrow), although the
number of PIC lesions remained unchanged. The area of
hyperfluorescence on late-phase FA (Figure 2B, arrow) or
hypofluorescence on initial-phase ICGA (Figure 2C, arrow)
corresponding to the lesion had expanded since the pa-
tient’s initial visit (Figure 1B, C). The patient was diagnosed
with recurrent PIC. Treatment with oral prednisolone
(30 mg/day) was restarted and continued for 3 months
with tapering. Three months after this second round of
treatment, BCVA remained unchanged, and the recurrent




In order to quantitatively examine choroidal blood flow
velocity in the present case of PIC, LSFG measurementsFigure 2 Photographs of the left eye 20 months (at the time of PIC recu
punctate subretinal yellowish-white lesion (arrow) at the nasal side of the fovea
of PIC lesions remained unchanged. B, C, An area of hyperfluorescence on late
corresponding to the recurrent PIC lesion had expanded since the initial visit (F
image taken at the same site depicted in Figure 1E showed the development
the recurrent PIC lesion (arrowhead), with surrounding IS/OS loss (arrows). Cho
the resumption of systemic prednisolone therapy, the size of the hyperrefle
hyperreflectivity within the lesion (arrowhead) and improved IS/OS integrityusing LSFG-NAVI (Softcare, Fukuoka, Japan) were ob-
tained for the eye with PIC and the fellow eye ten con-
secutive times before treatment, as well as at 1, 3 and
12 months after the initiation of oral prednisolone ther-
apy. The current study was approved by the ethics
committee of Hokkaido University Hospital. Informed
consent was obtained after an explanation of the nature
and possible consequences of the study, which followed
the standard of care outlined in the Declaration of
Helsinki. The pupils were dilated with 0.5% tropicamide
and 0.5% phenylephrine hydrochloride 20 min prior to
LSFG testing. During each measurement, eye movement
and focus adjustment were monitored using live-capture
images. To evaluate the change in relative blood flow
velocity at various retinal sites in the PIC eye, measure-
ment circles were set as follows: Circle 1 at the fovea;
Circle 2 at a lesion site with exudate; and Circle 3 at a
normal-appearing retinal site (Figure 3A). A single circle
was set at the center of the macula in the fellow eye.
The positions of circles were determined manually by
comparing the fundus photographs and the LSFG color
map images. The mean blur rate (MBR), a quantitative
index of relative blood flow velocity, was calculated
in each circle using LSFG Analyzer software (v 3.0.47;
Softcare) that automatically set each circle at the samerrence, A-D) and 23 months (E) after the initial visit. A, The size of a
OS had enlarged since the last visit (Figure 1A, F), although the number
-phase FA (B, arrow) or hypofluorescence on initial-phase ICGA (C, arrow)
igure 1B, C). D, A cross-sectional enhanced-depth imaging (EDI)-OCT
of a hump-shaped hyperreflective chorioretinal nodule corresponding to
roidal thickness beneath the lesion was 164.0 μm. E, Three months after
ctive lesion on EDI-OCT remained unchanged with slightly increased
. Choroidal thickness at the lesion site decreased to 122.7 μm.
Figure 3 Changes in the laser speckle flowgraphy (LSFG) color map for the left eye with PIC (B-E). A, B, Three circles were created on the
LSFG color map at the initial visit (B), based on the fundus photography at the initial visit (A, identical to Figure 1A). Circles 1–3 were located on
the fovea, the lesion site and the normal-appearing retinal site, respectively. Red indicates high MBR and blue indicates low MBR. C, D, In the LSFG
color maps obtained 3 and 12 months after systemic prednisolone therapy, MBR had increased at each circle compared to pretreatment values.
E, F, LSFG color map at the time of PIC recurrence (20 months after the initial visit). MBR was lower at this point as compared to 12 months after
treatment at each circle (D) and increased again after retreatment (23 months after the initial visit).
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follow-up. To evaluate changes in average MBR, the
rate of change in average MBR vs. initial baseline value
was utilized, as previously described [11,12]. This ap-
proach was possible with the use of MBR as a quantita-
tive index of “relative” blood flow velocity.
When LSFG measurements are taken for patients with
poor visual acuity, the reproducibility of MBR values de-
creases due to poor visual fixation. In addition, when a
lesion such as a subretinal hematoma or bullous retinal
detachment blocks laser beam radiation, precise mea-
surements can be difficult to obtain. We assessed the
present case with PIC as suitable for LSFG measure-
ments, because this patient maintained good visual acuity
during the follow-up without any pathology that would
block LSFG measurements.
Hemodynamics
Within a certain range, the relationship between chor-
oidal blood flow and ocular perfusion pressure (OPP) is
bilinear in healthy subjects with normal eyes, as previ-
ously demonstrated [13]. To exclude the possibility of suchphysiological responses from the results, the patient’s blood
pressure and intraocular pressure (IOP) were measured to
calculate OPP. Mean blood pressure (BPm) was calculated
from systolic blood pressure (BPs) and diastolic blood
pressure (BPd), according to the following equation:
BPm=BPd + 1/3(BPs-BPd). OPP was calculated using the
following equation: OPP = 2/3 BPm-IOP [14].
Results
LSFG data
The changes in a composite pseudo-color map and the
mean MBR during oral corticosteroid treatment at each
circle are shown in Figures 3 and 4. The color map demon-
strated that MBR increased within the circles 12 months
after systemic corticosteroid therapy (Figure 3B-D). Im-
portantly, MBR was shown to decrease at the recurrence
of PIC (Figure 3E) and to increase again after retreatment
(Figure 3F). The average MBR values were 8.7 ± 0.58,
11.95 ± 0.86, 10.12 ± 0.60, 10.44 ± 1.56, 9.30 ± 1.18 and
10.65 ± 0.65 in Circle 1; 4.95 ± 0.43, 7.38 ± 0.67, 6.15 ± 0.44,
7.10 ± 1.04, 3.49 ± 0.49 and 5.15 ± 0.39 in Circle 2;
and 10.83 ± 0.61, 12.68 ± 0.72, 11.32 ± 0.55, 12.08 ± 1.35,
Figure 4 Trends in MBR in PIC eyes and the fellow eye after the systemic administration of corticosteroids. In the PIC eye, MBR increased
at each circle, sequentially, after the initiation of systemic corticosteroid administration. Although corticosteroid treatment was discontinued after
4 months, MBR remained increased by 20.0%, 43.3% and 18.2%, respectively, at 12 months after treatment compared with baseline measurements
(100%). At the time of PIC recurrence (20 months after the initial visit), however, the MBR values in each circle showed decreases of 13-73%
compared to the 12-month values. Three months after the resumption of systemic corticosteroid treatment (23 months after baseline), 20-30% increases
in MBR compared to the values at 20 months were noted in all circles. However, MBR at the macula in the fellow eye remained unchanged or showed
little change (−4.5 ± 4.2%) during follow-up.
Hirooka et al. BMC Ophthalmology 2014, 14:73 Page 5 of 8
http://www.biomedcentral.com/1471-2415/14/738.31 ± 1.16 and 10.88 ± 0.57 in Circle 3 before treat-
ment and at 1, 3, 12, 20, and 23 months after treatment,
respectively. The MBR at the macula of the fellow eye
was 10.2 ± 0.56, 10.63 ± 0.53, 10.38 ± 0.32, 9.90 ± 0.59,
9.74 ± 0.54 and 10.44 ± 1.12 before treatment and at 1, 3,
12, 20 and 23 months after treatment, respectively. When
the changing rates of macular flow were compared with
the mean MBR levels before treatment (100%), 37.4%,
16.3%, 20.0%, 6.9% and 22.4% increases were detected in
Circle 1 (the fovea) at 1, 3, 12, 20, and 23 months aftertreatment, respectively (Figure 4). Similarly, in Circle 2
(the lesion site), 49.1%, 24.2%, 43.4%, −29.5% and 4.4% in-
creases were also noted at 1, 3, 12, 20 and 23 months after
treatment, respectively. In Circle 3 (normal-appearing area
apart from the lesion), 17.1%, 14.5%, 18.2%, −23.3% and
0.5% increases were measured at 1, 3, 12, 20 and 23
months after treatment, respectively. In contrast, MBR in
the fellow eye (the macula) showed little or no change with
4.2%, 1.8%, −2.9%, −4.5% and 2.4% increases at 1, 3, 12, 20
and 23 months, respectively (Figure 4).
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OPP was unaltered throughout the course of the disease,
with values of 31.0, 30.1, 29.1, 30.9, 30.0 and 32.0 mmHg
measured before treatment and at 1, 3, 12, 20 and
23 months after treatment, respectively. OPP in the fel-
low eye was 30.0, 33.0, 28.4, 29.8, 31.0 and 30.0 mmHg
before treatment, and at 1, 3, 12, 20 and 23 months after
treatment, respectively.
Enhanced depth imaging (EDI)-OCT findings
EDI-OCT was performed at the time of PIC recurrence
in the left eye (20 and 23 months after the initial visit).
The OCT image of the area presented in Figure 1E
showed a hump-shaped hyperreflective chorioretinal nod-
ule corresponding to the recurrent PIC lesion (Figure 2D,
arrowhead), with surrounding areas showing a loss of IS/
OS integrity (Figure 2D, arrows). Average thickness of the
choroid in the area surrounding the lesion was measured
by 3 authors (K.H., Y.H. and M.S.) as 164.0 ± 0.8 μm.
Three months after retreatment, the size of the nodule ex-
hibited no change with slightly increased hyperreflectivity
within the lesion (Figure 2E, arrowhead) and the recovery
of IS/OS integrity. At the lesion site, choroidal thickness
decreased to 122.7 ± 1.9 μm.
Discussion
In the present study, we examined chronological changes
in choroidal blood flow velocity at the macula using
LSFG in a patient with PIC. MBR at the lesion site and
normal retinal sites surrounding the macula in a PIC eye
showed 30–50% increases one month after oral prednis-
olone therapy, whereas MBR at the macula in the fellow
eye increased only 4% during the same period. Although
corticosteroid treatment was discontinued after 3 months,
the MBR at all sites examined in the PIC eye at 12 months
after treatment remained elevated by 20–40% compared
to baseline values, along with improvements in visual
function and outer retinal morphology. This increase in
blood flow was also observed during the course of PIC
recurrence, in association with decreased choroidal
thickness at the lesion site on EDI-OCT images. To our
knowledge, this is the first report in which choroidal circu-
lation hemodynamics was measured quantitatively in a pa-
tient with PIC.
Measurements of MBR at the fovea appear to reflect
mainly choroidal blood flow velocity because there are
no large retinal vessels at the fovea. In the present patient,
OPP after systemic corticosteroid therapy remained un-
changed compared to the pretreatment value. Therefore,
changes in MBR at the macula during follow-up in the PIC
eye were due to changes in the velocity of choroidal blood
flow but not the systemic circulation. At the time of PIC
recurrence, moreover, MBR decreased by 73% compared
to the value recorded 12 months after the first treatment.This value had increased by 30% again three months after
retreatment. Twelve months after the first treatment, it re-
mains unknown whether MBR returned to physiologically
normal levels before the onset of PIC, because LSFG was
not performed prior to the initial onset of PIC. However,
changes in the MBR, including those observed at the time
of recurrence, suggest that choroidal blood flow velocity at
the lesion area decreased at the acute phase of PIC but
then increased as the associated lesions healed.
Recently, SD-OCT revealed RPE elevation with hyper-
reflective sub-RPE nodules (Stage II) corresponding to
active PIC lesions and subsequently invading the photo-
receptors through the RPE breakthrough (chorioretinal
nodules, Stage III) [6,7]. Therefore, active PIC lesions
appear to affect at least the inner choroid. The wave-
length used in laser Doppler flowmetry (670 nm) [15],
which is shorter than that used in LSFG (830 nm), pre-
dominantly detects red blood cells moving in the chorio-
capillaris rather than the large choroidal vessels behind
it [14]. Accordingly, our data suggest that the choroidal
circulatory impairment in PIC extends not only to the
inner choroid but also to the deeper layer of the chor-
oid. Furthermore, there were changes detected in the
MBR and mfERG responses corresponding not only to
the sites of PIC lesions but to normal-appearing retinal
sites as well. These results suggest that choroidal circu-
latory disturbance extended over an area in the poster-
ior pole wider than the PIC lesion sites per se, which is
consistent with our recent data on acute macular neu-
roretinopathy [12].
The mechanism causing choroidal circulation impair-
ment in PIC remains largely unknown. In this study,
choroidal thickness decreased and MBR increased con-
currently with regression of recurrent PIC, suggesting
that choroidal thickness had increased at the active
phase, while MBR values had decreased in comparison
with those at the remission phase. Recently, another
study also demonstrated increased choroidal thickness
throughout the posterior pole and/or lesion sites in 30%
of eyes with acute PIC [7]. These results suggest that
choroidal blood flow decreases together with increases
in choroidal thickness during the acute stage of PIC. In
an investigation of Vogt–Koyanagi–Harada (VKH) dis-
ease, which involves choroiditis predominantly affecting
the stroma, previous EDI-OCT [16] and LSFG [17] data
demonstrated that macular choroidal blood flow velocity
decreased along with increases in choroidal thickness
during the acute stage of this disease. Notably, systemic
corticosteroid therapy reversed these trends. Further-
more, in acute zonal occult outer retinopathy (AZOOR)
and acute macular neuroretinopathy, in association with
the AZOOR complex as well as PIC, choroidal blood
flow velocity at the lesion site decreases during the acute
stage of the diseases [12,18]. In contrast, both blood flow
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stage of central serous chorioretinopathy (CSC) [11,19],
which involves a non-inflammatory (i.e., sympathetic or
adrenergic) cause. Thus, investigating the changes in
MBR and choroidal thickness over the course of diseases
may help elucidate their pathogenesis. The LSFG and
EDI-OCT results obtained for our PIC patient were
comparable to previous observations in VKH disease
and showed an “inflammatory pattern” in the choroid.
Therefore, our results suggest that inflammation is in-
volved in the pathogenesis of choroidal circulation
impairment observed in PIC eyes. Systemic cortico-
steroid therapy may lead to the improvement of circu-
lation disturbance following resolution of inflammation
in the choroid.
In this case, there is a possibility that corticosteroid it-
self exerted some influence on choroidal circulation be-
sides the MBR changes due to the resolution of PIC.
MBR at the macula had increased approximately 5.0% at
1 month after corticosteroid pulse therapy in patients
with thyroid-associated ophthalmopathy that developed
no retinal or choroidal findings [18]. Because this value
of 5% is similar to the MBR value observed in the PIC
patient’s fellow eye at the same phase, these results sug-
gest that the influence of corticosteroids on MBR is
slight but significant. In our case with PIC, however, an in-
crease in MBR of approximately 20% was maintained even
at 12 months after treatment was initiated (prednisolone
was tapered up to 4 months). Conversely, there was little
change in average MBR in the fellow eye over the same
time period. Therefore, it is reasonable to think that the in-
creases in MBR observed in this case stemmed largely from
the amelioration of PIC-associated choroidal circulation
disturbance.
It would not be fully elucidated whether choroidal
thickness changes may affect MBR values, although the
effect of choroidal thickening on MBR is estimated to be
minimal or negligible compared to the extent of the
MBR changing ratio [20]. The MBR represents the vel-
ocity of erythrocytes [9,10]. Actually, the MBR changes
seen in CSC and VKH disease, both of which involve in-
creased choroidal thickness together with serous retinal
detachment (SRD) [16,18], are in the opposite direction
(decrease in CSC vs. increase in VKH disease) during re-
gression of the SRD [11,17]. We consider that choroidal
thickening develops due to hyperperfusion associated with
sympathetic action in CSC [11], whereas choroiditis which
is represented as diffuse infiltration of the lymphocytes in
the choroidal stroma in VKH disease [17]. Thus, the MBR
changes during the course of disease exhibit specific pat-
terns according to the condition’s pathogenesis, independ-
ently of the choroidal thickness changes during follow-up.
These observations may reduce our attention paid to
changes in choroidal thickness for MBR changes.This study has certain limitations. We present a single
PIC patient. One examiner (K.H.) decided the site of
each circle for measuring the MBR. These decisions may
have been biased because the examiner was not masked
to the patient’s diagnosis.
Conclusions
Macular choroidal blood flow velocity increased and
choroidal thickness decreased concurrently with regres-
sion of PIC. These results suggest that inflammation-
related impairments in choroidal circulation extend be-
yond the lesion sites and contribute to the pathogenesis
of PIC. Further research with a larger number of cases is
required to further elucidate the relationship between
outer retinal morphology and choroidal circulation in
PIC.
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